Published in Lung Cancer on October 20, 2011
Cancer cachexia: impact, mechanisms and emerging treatments. J Cachexia Sarcopenia Muscle (2012) 1.21
Broad targeting of resistance to apoptosis in cancer. Semin Cancer Biol (2015) 1.03
Epigenetic mechanisms in respiratory muscle dysfunction of patients with chronic obstructive pulmonary disease. PLoS One (2014) 0.88
The assessment and impact of sarcopenia in lung cancer: a systematic literature review. BMJ Open (2014) 0.87
Motor protein function in skeletal abdominal muscle of cachectic cancer patients. J Cell Mol Med (2013) 0.81
Cancer cachexia-when proteasomal inhibition is not enough. J Cachexia Sarcopenia Muscle (2016) 0.81
Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia. Br J Cancer (2016) 0.78
Effect of the specific proteasome inhibitor bortezomib on cancer-related muscle wasting. J Cachexia Sarcopenia Muscle (2015) 0.77
Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia - can findings from animal models be translated to humans? BMC Cancer (2016) 0.77
Positive Prehabilitative Effect of Intense Treadmill Exercise for Ameliorating Cancer Cachexia Symptoms in a Mouse Model. J Cancer (2016) 0.75
Impact of age on functional exercise correlates in patients with advanced lung cancer. Onco Targets Ther (2013) 0.75
Detection of Pancreatic Cancer-Induced Cachexia Using a Fluorescent Myoblast Reporter System and Analysis of Metabolite Abundance. Cancer Res (2015) 0.75
Effects of systematic rehabilitation programs on quality of life in patients undergoing lung resection. Mol Clin Oncol (2012) 0.75
Preserved muscle oxidative metabolic phenotype in newly diagnosed non-small cell lung cancer cachexia. J Cachexia Sarcopenia Muscle (2015) 0.75
Cancer-induced muscle wasting: latest findings in prevention and treatment. Ther Adv Med Oncol (2017) 0.75
The value of physical performance measurements alongside assessment of sarcopenia in predicting receipt and completion of planned treatment in non-small cell lung cancer: an observational exploratory study. Support Care Cancer (2017) 0.75
Recommendations on the use of exercise testing in clinical practice. Eur Respir J (2007) 3.15
Short- and long-term efficacy of a community-based COPD management programme in less advanced COPD: a randomised controlled trial. Thorax (2009) 3.12
Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids. Histochem Cell Biol (2001) 2.68
Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations. Thorax (2001) 1.94
Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB. FASEB J (2001) 1.88
Factors contributing to alterations in skeletal muscle and plasma amino acid profiles in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (2000) 1.73
Association of fatigue with an acute phase response in sarcoidosis. Eur Respir J (1999) 1.62
Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr (2000) 1.58
Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J Clin Oncol (1995) 1.56
Dual-energy X-ray absorptiometry in the clinical evaluation of body composition and bone mineral density in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (1998) 1.51
Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci (Lond) (1999) 1.49
Response of Saccharomyces cerevisiae to severe osmotic stress: evidence for a novel activation mechanism of the HOG MAP kinase pathway. Mol Microbiol (2000) 1.45
Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med (2000) 1.38
Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (2000) 1.38
Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J (1994) 1.30
Effect of training in the fasted state on metabolic responses during exercise with carbohydrate intake. J Appl Physiol (1985) (2008) 1.28
Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease. Eur Respir J (1997) 1.26
Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. Int J Obes Relat Metab Disord (2001) 1.22
Total free living energy expenditure in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1997) 1.16
Enteral nutrition in intensive care patients: a practical approach. Working Group on Nutrition and Metabolism, ESICM. European Society of Intensive Care Medicine. Intensive Care Med (1998) 1.09
Passive transverse mechanical properties of skeletal muscle under in vivo compression. J Biomech (2001) 1.07
The use of bioelectrical impedance analysis to predict total body water in patients with cancer cachexia. Am J Clin Nutr (1995) 1.07
An alternative function for human uncoupling protein 3: protection of mitochondria against accumulation of nonesterified fatty acids inside the mitochondrial matrix. FASEB J (2001) 1.07
Different patterns of chronic tissue wasting among patients with chronic obstructive pulmonary disease. Clin Nutr (1999) 1.06
Physiological changes in male competitive cyclists after two weeks of intensified training. Int J Sports Med (1992) 1.04
Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 1.04
Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function. Eur J Clin Nutr (1998) 1.04
Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD. Eur Respir J (2007) 1.03
Effects of an acute exacerbation on nutritional and metabolic profile of patients with COPD. Eur Respir J (1997) 1.01
Interval versus continuous training in patients with severe COPD: a randomized clinical trial. Eur Respir J (1999) 1.01
Exercise-induced lactate increase in relation to muscle substrates in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 1.01
Enhanced levels of whole-body protein turnover in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 1.01
Plasma and muscle amino acid levels in relation to resting energy expenditure and inflammation in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 1.00
Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 0.99
Is INTERdisciplinary COMmunity-based COPD management (INTERCOM) cost-effective? Eur Respir J (2009) 0.97
Loss of 50% of excess weight using a very low energy diet improves insulin-stimulated glucose disposal and skeletal muscle insulin signalling in obese insulin-treated type 2 diabetic patients. Diabetologia (2007) 0.95
Decreased mechanical efficiency in clinically stable patients with COPD. Thorax (1997) 0.94
Plasma concentration of total leptin and human lung-cancer-associated cachexia. Clin Sci (Lond) (1997) 0.94
Analysis of the energy balance in lung cancer patients. Cancer Res (1994) 0.94
Uncoupling protein 3 content is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes (2001) 0.92
Metabolic switching of human myotubes is improved by n-3 fatty acids. J Lipid Res (2010) 0.88
The disruption of myofibre structures in rat skeletal muscle after forced lengthening contractions. Pflugers Arch (1998) 0.88
Acute effects of different nutritional supplements on symptoms and functional capacity in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (2001) 0.87
Altered glutamate metabolism is associated with reduced muscle glutathione levels in patients with emphysema. Am J Respir Crit Care Med (2000) 0.87
Early non-elective readmission for chronic obstructive pulmonary disease is associated with weight loss. Clin Nutr (2000) 0.87
Total daily energy expenditure relative to resting energy expenditure in clinically stable patients with COPD. Thorax (1997) 0.87
A physiological/psychological indicator of over-reaching during intensive training. Int J Sports Med (1993) 0.85
Metabolism in patients with small cell lung carcinoma compared with patients with non-small cell lung carcinoma and healthy controls. Thorax (1997) 0.85
Serum lactate dehydrogenase and its isoenzyme pattern in ex-coalminers. Respir Med (1997) 0.83
Effects of exercise on amino acid metabolism in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 0.83
Metabolic and ventilatory response pattern to arm elevation in patients with COPD and healthy age-matched subjects. Eur Respir J (1995) 0.82
Elevated inosine monophosphate levels in resting muscle of patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 0.82
beta-Adrenoceptor-mediated thermogenesis and lipolysis in patients with chronic obstructive pulmonary disease. Am J Physiol Endocrinol Metab (2001) 0.81
Body-water compartments measured by bio-electrical impedance spectroscopy in patients with chronic obstructive pulmonary disease. Clin Nutr (1998) 0.81
The effects of treatment with chemotherapy on energy metabolism and inflammatory mediators in small-cell lung carcinoma. Br J Cancer (1997) 0.81
Controlled lengthening or shortening contraction-induced damage is followed by fiber hypertrophy in rat skeletal muscle. Int J Sports Med (2000) 0.80
Peroxisome proliferator-activated receptors: a therapeutic target in COPD? Eur Respir J (2008) 0.80
In situ assessment of shortening and lengthening contractile properties of hind limb ankle flexors in intact mice. Pflugers Arch (2001) 0.80
Bioelectrical impedance analysis to assess changes in total body water in patients with cancer. Clin Nutr (1999) 0.80
TNF-alpha and hypermetabolism in chronic obstructive pulmonary disease. Clin Nutr (1999) 0.79
Efficacy of Curosurf in a rat model of acute respiratory distress syndrome. Eur Respir J (1998) 0.79
GLUT-4 expression is not consistently higher in type-1 than in type-2 fibres of rat and human vastus lateralis muscles; an immunohistochemical study. Pflugers Arch (2000) 0.79
The Conconi test. Int J Sports Med (1997) 0.79
Anabolic steroids. Curr Opin Clin Nutr Metab Care (1999) 0.79
UVB-induced mutagenesis in hairless lambda lacZ-transgenic mice. Environ Mol Mutagen (1997) 0.78
Prevalence and pathophysiology of nutritional depletion in chronic obstructive pulmonary disease. Respir Med (1993) 0.78
Enteral nutrition in intensive care patients: a practical approach. Clin Nutr (1999) 0.78
Overtraining--what do lactate curves tell us? Br J Sports Med (1994) 0.78
Muscle metabolic status in patients with severe COPD with and without long-term prednisolone. Eur Respir J (2000) 0.78
Contraction failure of skeletal muscle of rats recovering from critical illness. Clin Sci (Lond) (1997) 0.77
Synergistic stimulation of myogenesis by glucocorticoid and IGF-I signaling. J Appl Physiol (1985) (2012) 0.77
Breathing efficiency during inspiratory threshold loading in patients with chronic obstructive pulmonary disease. Clin Physiol (1998) 0.77
Acute effects of nebulized salbutamol on resting energy expenditure in patients with chronic obstructive pulmonary disease and in healthy subjects. Respiration (1998) 0.77
Contractile properties and histochemical characteristics of the rat diaphragm after prolonged triamcinolone treatment and nutritional deprivation. J Muscle Res Cell Motil (1998) 0.76
Different effects of corticosteroid-induced muscle wasting compared with undernutrition on rat diaphragm energy metabolism. Eur J Appl Physiol (2000) 0.76
Enzyme activity of rat tibialis anterior muscle differs between treatment with triamcinolone and prednisolone and nutritional deprivation. Eur J Appl Physiol Occup Physiol (1999) 0.76
Detection of bone marrow metastases in small cell lung cancer. Comparison of magnetic resonance imaging with standard methods. Eur J Cancer (1996) 0.75
Recomendações sobre o uso dos testes de exercício na prática clínica. Rev Port Pneumol (2015) 0.75
Metabolic support and energy supply in chronic respiratory failure. Monaldi Arch Chest Dis (1993) 0.75
Influence of nucleotide excision repair on N-hydroxy-2-acetylaminofluorene-induced mutagenesis studied in lambda lacZ-transgenic mice. Environ Mol Mutagen (1998) 0.75
Analysis of the metabolic and ventilatory response to self-paced 12-minute treadmill walking in patients with severe chronic obstructive pulmonary disease. J Cardiopulm Rehabil (1998) 0.75
Analysis of body water compartments in relation to tissue depletion in clinically stable patients with chronic obstructive pulmonary disease. Am J Clin Nutr (1997) 0.75